Advertisement.

CBIA Projected Dividend Yield

Canopus Biopharma Inc ( OTCBB : CBIA )

Canopus Biopharma is a biopharmaceutical company focused on the development and commercialization of drugs that address unmet medical needs. Co.'s pipeline of product candidates and drugs in development are: CB008 and CB007 for Ebola Virus; Dengovir™ CB010 for Dengue Virus; Rapha-D therapeutic topical agent for diabetic foot ulcers; and PTP-100 hyper-immune plasma therapeutic product for Equine Laminitis. Co.'s other pipeline molecules consist of: the development of a novel anti-bacterial compound to inhibit multi-drug resistant bacteria; CB2700 drug designed to stimulate the production of Stem Cell Factor in animals and patients; and three drugs against the tuberculosis bacteria.

20 YEAR PERFORMANCE RESULTS

CBIA Dividend History Detail
CBIA Dividend News
CBIA Competitors News

# of Shares: 0

Closing Price: 0.00

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000